Nipocalimab (Anti-FcRn) (FCGRT & B2M)
Nipocalimab (anti-FcRn) (FCGRT & B2M) is a fully human monoclonal antibody that targets the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. MW: 142.12 KD.
| Trivial name | M281 |
| Catalog Number | A2948 |
| CAS# | 2211985-36-1 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/nipocalimab-anti-fcrn-fcgrt--b2m.html |